120
Rani Therapeutics Holdings, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
Assets
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
101
FY23:
50.8
FY24:
29.7
FY25:
53.3
(positive)
Change from FY21 to FY25
millions USD
FY21:
4.61
FY22:
7.10
FY23:
7.07
FY24:
6.89
FY25:
5.30
Total assets
Change from FY21 to FY25
millions USD
FY21:
124
FY22:
108
FY23:
57.9
FY24:
36.6
FY25:
58.6
Liabilities & Equity
(negative)
Change from FY21 to FY25
millions USD
FY21:
2.64
FY22:
4.82
FY23:
7.99
FY24:
19.9
FY25:
12.7
(negative)
millions USD
FY21:
0
FY22:
29.2
FY23:
24.5
FY24:
13.3
FY25:
4.44
(positive)
Change from FY21 to FY25
millions USD
FY21:
47.4
FY22:
36.9
FY23:
12.9
FY24:
1.99
FY25:
33.0
All amounts in millions USD